Hippocampal neuroplasticity in major depressive disorder.
about
cAMP/PKA/CREB/GLT1 signaling involved in the antidepressant-like effects of phosphodiesterase 4D inhibitor (GEBR-7b) in ratsSex Differences in Gray Matter Volume of the Right Anterior Hippocampus Explain Sex Differences in Three-Dimensional Mental RotationMolecular, Functional, and Structural Imaging of Major Depressive Disorder.Molecular Signatures of Psychosocial Stress and Cognition Are Modulated by Chronic Lithium Treatment.Anti-ribosomal-phosphoprotein autoantibodies penetrate to neuronal cells via neuronal growth associated protein, affecting neuronal cells in vitro.Gamma-H2AX upregulation caused by Wip1 deficiency increases depression-related cellular senescence in hippocampus.Ketamine produces antidepressant-like effects through phosphorylation-dependent nuclear export of histone deacetylase 5 (HDAC5) in rats.Serum KIBRA mRNA and Protein Expression and Cognitive Functions in DepressionChronic Mild Stress Modulates Activity-Dependent Transcription of BDNF in Rat Hippocampal SlicesCognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders.Homer1a protein expression in schizophrenia, bipolar disorder, and major depression.Autobiographical memory dysfunctions in depressive disorders.Ketamine modulates subgenual cingulate connectivity with the memory-related neural circuit-a mechanism of relevance to resistant depression?Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.Effects of escitalopram and paroxetine on mTORC1 signaling in the rat hippocampus under chronic restraint stress.Reduced marker of vascularization in the anterior hippocampus in a female monkey model of depression.Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus.MicroRNAs as biomarkers for major depression: a role for let-7b and let-7c.Therapeutic Effect of Astroglia-like Mesenchymal Stem Cells Expressing Glutamate Transporter in a Genetic Rat Model of Depression.Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic ApoptosisMicroglia: An Interface between the Loss of Neuroplasticity and DepressionAutomated Tracking of Motion and Body Weight for Objective Monitoring of Rats in Colony HousingAssociation between hippocampus volume and symptom profiles in obsessive-compulsive disorder.Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort.Alternations of White Matter Structural Networks in First Episode Untreated Major Depressive Disorder with Short Duration.Mapping the structural and functional network architecture of the medial temporal lobe using 7T MRI.Increased hippocampal tail volume predicts depression status and remission to anti-depressant medications in major depression.Genome-wide analysis of LPS-induced inflammatory response in the rat ventral hippocampus: Modulatory activity of the antidepressant agomelatine.The antidepressant action of 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid is mediated by phosphorylation of histone deacetylase 5.Zinc, Magnesium, Selenium and Depression: A Review of the Evidence, Potential Mechanisms and Implications.Sex-specific hippocampus volume changes in obstructive sleep apneaMicroRNA Profiling and Bioinformatics Target Analysis in Dorsal Hippocampus of Chronically Stressed Rats: Relevance to Depression Pathophysiology
P2860
Q28602109-D35BB1D2-8534-45EE-A19B-09DFD6154D42Q30828557-403CF5ED-4DD0-43C3-B2CA-835D3D9BF12DQ31090058-2CF22FE5-3D23-47C9-9A31-98F7A70B7838Q35880985-22184000-9E69-44DD-8951-DF1A1B396F03Q36011424-0ED805C9-999F-4C31-8CAF-467F54067BDBQ36148914-2C9DE255-EF2D-4E48-8DCE-C432D494B7F9Q36419883-5B38C275-DDAD-48CA-8B8C-F4C1EBA10FFCQ36473465-64946123-5674-461C-9748-0EBC82838739Q36529121-E76DB49B-F72E-4AF1-8F7E-FBFA62ED205DQ36813681-9D92E0F0-05B4-442D-A27A-7E0646F7492DQ38621050-E0BAA87C-B447-4520-94B6-1099B7D5CF64Q38621902-791D4FF9-2A53-4D9F-923C-95BBB29F504CQ38647409-4E0512BB-04C7-422F-AA0D-5A1946054668Q38802908-76BF26E9-765C-45F3-8E4F-4566BCF85B84Q38818235-80CA35F9-E64D-4856-B452-2F0EBF1D6D18Q39595780-323CAC13-C477-4301-9B68-44A9A960EFBBQ40216225-2DEB1822-0F00-490C-9815-36D8D996F5F2Q41084643-36604DC0-19C6-4F91-A40A-9C1D24610A95Q41430366-72E4D01E-5E21-4D33-A683-DCB506A4AB08Q41673202-FCB41C66-29CA-4ACC-AFCD-CCD10C6022A6Q41699494-7050DAD6-0ACC-48C2-8264-AD84654AD400Q42147964-585AEC80-33C5-47E8-920C-55892CC3AF79Q47114403-52EDD9D0-1CA5-48B2-A343-36747EFC988CQ47222599-125181E2-21B2-4F3A-9B3E-20B8FF2D6EC5Q47232681-FAC61D64-9A41-4DEC-A456-EC4D64018ABAQ47328350-7AAD41FE-8521-4803-B21F-0813052EB5E4Q47603898-D6E6D501-087D-4DE3-B582-FDB8808E9D31Q47936163-8182B058-35BE-4D62-8A35-AF907CFC0738Q53079998-8874BFC5-01FB-43C3-BFFE-A668F34A2DE4Q55276164-B0F6D92B-F8B5-40FF-8D31-E74CD673D859Q57899529-FD2C8B89-E09D-45FD-9062-412F5E66F143Q58798997-56AEC2D0-C47F-4C1F-A429-BB0EACFF1B2E
P2860
Hippocampal neuroplasticity in major depressive disorder.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Hippocampal neuroplasticity in major depressive disorder.
@ast
Hippocampal neuroplasticity in major depressive disorder.
@en
type
label
Hippocampal neuroplasticity in major depressive disorder.
@ast
Hippocampal neuroplasticity in major depressive disorder.
@en
prefLabel
Hippocampal neuroplasticity in major depressive disorder.
@ast
Hippocampal neuroplasticity in major depressive disorder.
@en
P1433
P1476
Hippocampal neuroplasticity in major depressive disorder.
@en
P2093
N J Coupland
N V Malykhin
P304
P356
10.1016/J.NEUROSCIENCE.2015.04.047
P407
P577
2015-04-28T00:00:00Z